Back to Treatments

Treatment

Shorter 4-Month Regimen (High-dose Rifapentine, Isoniazid, Pyrazinamide, Moxifloxacin then High-dose Rifapentine, Isoniazid, Moxifloxacin for active TB)

1
Conditions
15
Trials
8,000
Participants
55%
Average Safety

Condition Evidence

Drug-susceptible tuberculosis

15 trials · 8,000 participants

94% effectiveness · 55% safety
Shorter 4-Month Regimen (High-dose Rifapentine, Isoniazid, Pyrazinamide, Moxifloxacin then High-dose Rifapentine, Isoniazid, Moxifloxacin for active TB) | DFDA